Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter January 30, 2019

Methodological issues are important in cannabinoids determination in bronchoalveolar lavage

Venerino Poletti and Claudia Ravaglia

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Rotolo MC, Pellegrini M, Martucci P, Giacobbe R, De Palma A, Pacifici R, et al. Cannabinoids determination in bronchoalveolar lavages of cannabis smokers with lung disease. Clin Chem Lab Med 2019;57:498–503.10.1515/cclm-2018-0426Search in Google Scholar PubMed

2. Klech H, Pohl W, editors. Technical recommendations and guidelines for bronchoalveolar lavage (BAL): report of the European Society of Pneumology task group. Eur Respir J 1989;2:561–85.Search in Google Scholar

3. Rennard SI, Aalbers R, Bleecker E, Klech H, Rosenwasser L, Olivieri D, et al. Bronchoalveolar lavage: performance, a sampling procedure, processing and assessment. Eur Respir J 1998;26:13S–5S.Search in Google Scholar

4. Moazed F, Burnham EL, Vandivier RW, O’Kane CM, Shyamsundar M, Hamid U, et al. Cigarette smokers have exaggerated alveolar barrier disruption in response to lipopolysaccharide inhalation. Thorax 2017;71:1130–6.10.1136/thoraxjnl-2015-207886Search in Google Scholar PubMed PubMed Central

Received: 2018-11-23
Accepted: 2018-12-27
Published Online: 2019-01-30
Published in Print: 2019-03-26

©2019 Walter de Gruyter GmbH, Berlin/Boston

Scroll Up Arrow